Companies Cryptocurrencies
Predictive Oncology Inc
Predictive Oncology Inc
Exchange: NasdaqGS
IPO Date: 18/12/2009
CEO: Dr. Carl Schwartz
Medical Instruments & Supplies Healthcare đź”—
  • POAI
  • 1.25
  • 81759752
    market cap
  • 0.05999994
If you bought

shares of Predictive Oncology Inc (POAI) on
You would have made
Old Price $12 Current Price $12

Predictive Oncology Inc. is focused on applying artificial intelligence (AI) to personalized medicine and drug discovery. It operates through its subsidiaries, Helomics Holding Corporation (Helomics), TumorGenesis Inc., Skyline Europe and Skyline Medical Inc. Helomics applies AI to its data gathered from patient tumors to both personalize cancer therapies for patients and focusses on the development of new-targeted therapies. Helomics’ clinical laboratory improvement amendments (CLIA)-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions. Its TumorGenesis Inc. is engaged in developing approach to tumors in the laboratory. Skyline Medical Inc. markets its STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions.

Address: 2915 Commers Dr Ste 900 Eagan MINNESOTA 55121

Stay updated.